Research at the University of Colorado found that 4:3 intermittent fasting resulted in greater weight loss than daily caloric ...

The Centers for Medicare & Medicaid Services said on Friday it did not move forward with a proposal put forth by the Biden ...

Some of the more than a dozen states that cover the high cost of GLP-1 drugs like Wegovy, Ozempic and Zepbound through ...

The decision counters a proposal by the Biden Administration to reimburse beneficiaries for the weight-loss medications.

New research suggests that fasting for three days a week may lead to greater weight loss than slightly reducing calories ...

The Trump administration has decided against implementing a proposal for Medicare and Medicaid to cover weight loss drugs, ...

"An appealing feature of [intermittent fasting] is that dieters do not have to focus on counting calories and restricting ...

Whether or not you choose to cover weight loss drugs, offering holistic support can make a meaningful difference in employee ...

The state is thinking about requiring Medicaid patients who want to use GLP-1s for weight loss to meet a certain number on the body-mass index or try diet and exercise programs or less expensive ...

It was surprising and exciting to me that it was better,” said Dr. Victoria Catenacci, co-lead study author and an associate ...

A 4:3 nonconsecutive intermittent fasting regimen was more tolerable and yielded somewhat greater weight loss at 1 year than ...